I am currently a PhD candidate in Clinical Pharmacology with expertise in pharmacometrics, clinical pharmacology, pharmacokinetics/pharmacodynamics, modeling and simulations, biostatistics, and model-informed drug development. Experienced in conducting and interpreting modeling and simulation analyses and statistical analyses to support study design and clinical pharmacology strategy across early- and late-stage development. Gaining experience in preparing scientific documents such as study reports, protocols, and exposure-response analyses. Possesses a strong foundation in clinical pharmacology with the ability to integrate knowledge across disciplines and contribute to drug development discussions and decision-making. Committed to advancing human health through innovative PK/PD approaches and the development of novel therapeutics. Recognized for professionalism, scientific rigor, and effective communication in collaborative, high-efficiency research environments.
Merck & Co., Inc., Rahway, NJ, USA •
01/2024 – 01/2024 •
Quantitative Pharmacology & Pharmacometrics